Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2022-04-14 00:00:00 ET · period of report 2022-04-12 · accession 0000315066-22-001561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-04-14 | 2022-04-12 | BEAM | FMR LLC | 10%, See Remark 1 | J - Other | $0.00 | -531.3K | 18.8K | -97% | $0 |
| MI | 2022-04-14 | 2022-04-13 | BEAM | FMR LLC | 10%, See Remark 1 | S - Sale | $50.41 | -19.5K | 3,200 | -86% | -$981.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-12 | J | D | 978,503 | $0.00 | 2,935,511 | I F-Prime Capital Partners Healthcare Fund V LP | — | — | (F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. |
| 2 | Common | Common Stock | 2022-04-12 | J | A | 509,490 | $0.00 | 509,995 | I Impresa Fund III Limited Partnership | — | — | (F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. |
| 3 | Common | Common Stock | 2022-04-12 | J | D | 509,332 | $0.00 | 663 | I Impresa Fund III Limited Partnership | — | — | (F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. |
| 4 | Common | Common Stock | 2022-04-12 | J | A | 137,845 | $0.00 | 141,151 | I F-Prime Capital Partners Healthcare Advisors Fund V LP | — | — | (F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. |
| 5 | Common | Common Stock | 2022-04-12 | J | D | 128,333 | $0.00 | 12,818 | I F-Prime Capital Partners Healthcare Advisors Fund V LP | — | — | (F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. |
| 6 | Common | Common Stock | 2022-04-13 | S | D | 3,200 | $50.80 | 0 | I F-Prime Inc. | — | — | |
| 7 | Common | Common Stock | 2022-04-12 | J | A | 422,120 | $0.00 | 2,490,515 | I Shares held by persons and entities whose shares are subject to reporting by the undersigned. | — | — | (F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. |
| 8 | Common | Common Stock | 2022-04-13 | S | D | 663 | $50.75 | 0 | I Impresa Fund III Limited Partnership | — | — | |
| 9 | Common | Common Stock | 2022-04-13 | S | D | 6,799 | $50.70 | 12,004 | I F-Prime Inc. | — | — | (F2) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.50 to $51.00. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2022-04-13 | S | D | 8,804 | $50.01 | 3,200 | I F-Prime Inc. | — | — | (F3) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $49.75 to $50.50. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2022-04-12 | J | A | 15,406 | $0.00 | 18,803 | I F-Prime Inc. | — | — | (F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. |